Search Results

Combining human iPSC biology and AI computing to accelerate drug discovery, improve drug safety, and advance precision medicine.

Principal Scientist Anders Cai Holm Hansen explains how CDMO AGC Biologics uses its global, single-use network and a strategy emphasizing “scale-out” manufacturing, to derisk demand uncertainty, speed timelines and conserve cash for emerging drug developers.

Vizgen, Inc. has announced a partnership with Scale Biosciences (ScaleBio) to combine their single-cell and spatial technologies for enhanced data analysis at the Advances in Genome Biology and Technology (AGBT) 2024 General Meeting in Orlando, Florida.

Scale Biosciences today announced the availability of three new datasets showcasing the performance of its newly released products, including the ScaleBio Single Cell Methylation Kit, ScaleBio Single Cell RNA Kit v1.1 with extended throughput, and ScaleBio CRISPR Guide Enrichment Kit, all of which are now shipping.

In this episode of Denatured, you’ll hear from Jack Crawford, CEO of Demeetra, and Magnus Gustavsson, chief commercial officer at NorthX Biologics. We unpack the evolution of cell line development — CHO cells, targeted integration, transposases and the collaboration models speeding biologics from sequence to GMP.

Scale Biosciences, Inc. (ScaleBio), a pioneer in single-cell sequencing and combinatorial indexing technologies, has transitioned from research and development to commercial stage with the release of its first generation single-cell transcriptomics scRNAseq profiling and analysis solution, establishing new standards for accessible, scalable, and low-cost single-cell sequencing.